Epstein Secrets

use other countries have rushed to buy up most of its supply, according to multiple individuals familiar with the situation." While The Hilt (12/7, Weixel, 2.98M) reports an Administration official "said nobody turned down additional Pfizer doses" and said the US "has contracts with five other companie

y believe he's at risk of committing further terrorist acts." Opinion: Al-Qaeda Persists Despite Shifting US Priorities, Is Poised For "Comeback." Colin P. Clarke, a Senior Research Fellow at The Soufan Center, writes in an op-ed in Newsweek (12/7, 1.53M) that Al-Qaeda "has sidestepped the dilemma of leadership

n." While The Hill <https://thehill.com/policy/healthcare/529131-trump-officials-deny-turning-down-additional- doses-of-pfizer-covid-vaccine> (12/7, Weixel, 2.98M) reports an Administration official "said nobody turned down additional Pfizer doses" and said the US "has contracts with five other companie

ey believe he's at risk of committing further terrorist acts." Opinion: Al-Qaeda Persists Despite Shifting US Priorities, Is Poised For "Comeback." Colin P. Clarke, a Senior Research Fellow at The Soufan Center, writes in an op-ed in Newsweek <https://www.newsweek.com/reports-al-qaedas-demise-are-greatly-exagge

se other countries have rushed to buy up most of its supply, according to multiple individuals familiar with the situation." While The Hill (12/7, Weixel, 2.98M) reports an Administration official "said nobody turned down additional Pfizer doses" and said the US "has contracts with five other companie

y believe he's at risk of committing further terrorist acts." Opinion: Al-Qaeda Persists Despite Shifting US Priorities, Is Poised For "Comeback." Colin P. Clarke, a Senior Research Fellow at The Soufan Center, writes in an op-ed in Newsweek (12/7, 1.53M) that Al-Qaeda "has sidestepped the dilemma of leadershi